TABLE 2.
Compound | FPA: IC50vs. DRIP-2 | SPA: IC50vs. [3H]rosiglitazone |
---|---|---|
GW9662 | ND | 0.13 ± 0.01 |
Rosiglitazone | 0.8 ± 0.2 | 0.48 ± 0.04 |
17 | 15 ± 1.7 | 1.7 ± 0.3 |
Compound | FPA: IC50vs. DRIP-2 | SPA: IC50vs. [3H]rosiglitazone |
---|---|---|
GW9662 | ND | 0.13 ± 0.01 |
Rosiglitazone | 0.8 ± 0.2 | 0.48 ± 0.04 |
17 | 15 ± 1.7 | 1.7 ± 0.3 |